CLINICAL_TRIALS
trial_result
· 2024-05-03
Clinical Trial Update: OPT101 in Type 1 Diabetes Patients [Phase 1]
Summary
This update reports the completion of a Phase 1 trial of OPT101 in patients with Type 1 diabetes mellitus.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Op-T LLC | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED